Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.54
-0.02 (-0.36%)
Sep 11, 2024, 3:28 PM EDT - Market open
Abeona Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -52.6 | -54.19 | -39.7 | -84.94 | -84.23 | -76.28 | Upgrade
|
| Depreciation & Amortization | 2.88 | 3.2 | 4.58 | 4.46 | 5.6 | 8.68 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0 | 0.05 | 0.14 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -1.07 | 5.66 | 32.47 | 32.92 | - | Upgrade
|
| Stock-Based Compensation | 5.94 | 4.77 | 3.05 | 8.92 | 8.19 | 8.24 | Upgrade
|
| Other Operating Activities | -1.43 | 12.02 | -11.32 | -8.31 | 0.88 | 0.1 | Upgrade
|
| Change in Accounts Receivable | 3.5 | - | 3 | -3 | - | 0.08 | Upgrade
|
| Change in Accounts Payable | 0.08 | 2.04 | -4.11 | 0.83 | -2.18 | -1.71 | Upgrade
|
| Change in Other Net Operating Assets | -0.58 | -3.83 | -4.78 | -16.09 | 3.81 | -1.93 | Upgrade
|
| Operating Cash Flow | -42.2 | -37.01 | -43.48 | -65.67 | -35.02 | -62.82 | Upgrade
|
| Capital Expenditures | -1.52 | -0.33 | -0.13 | -4.15 | -1.34 | -6.31 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.2 | 1.73 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.2 | Upgrade
|
| Investment in Securities | -57.69 | 0.34 | -25.57 | 70.21 | -82.38 | 66.48 | Upgrade
|
| Investing Cash Flow | -59.16 | 0.21 | -23.96 | 66.06 | -83.71 | 59.98 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 1.76 | - | Upgrade
|
| Total Debt Issued | 20 | - | - | - | 1.76 | - | Upgrade
|
| Net Debt Issued (Repaid) | 20 | - | - | - | 1.76 | - | Upgrade
|
| Issuance of Common Stock | 110.88 | 37.39 | 46.96 | 24.03 | 0.18 | 113.9 | Upgrade
|
| Repurchase of Common Stock | -0.18 | -0.18 | -0.01 | - | - | - | Upgrade
|
| Other Financing Activities | -1.13 | -0.15 | - | 0.83 | - | - | Upgrade
|
| Financing Cash Flow | 129.57 | 37.06 | 43.17 | 24.86 | 1.94 | 113.9 | Upgrade
|
| Net Cash Flow | 28.2 | 0.26 | -24.27 | 25.26 | -116.8 | 111.06 | Upgrade
|
| Free Cash Flow | -43.72 | -37.34 | -43.61 | -69.82 | -36.36 | -69.13 | Upgrade
|
| Free Cash Flow Margin | - | -1066.86% | -3084.37% | -2327.20% | -363.55% | - | Upgrade
|
| Free Cash Flow Per Share | -1.48 | -1.75 | -5.55 | -17.73 | -9.81 | -34.32 | Upgrade
|
| Cash Interest Paid | 1.29 | - | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -20.5 | -18.89 | -19.73 | -62.58 | -17.1 | -20.63 | Upgrade
|
| Unlevered Free Cash Flow | -19.1 | -18.63 | -19.27 | -60.3 | -14.53 | -20.38 | Upgrade
|
| Change in Net Working Capital | -9.06 | -3.86 | -1.52 | 33.67 | -3.34 | -17.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.